Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 7.69 percent. This is a 20 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $37.178 million which missed the analyst consensus estimate of $39.986 million by 7.02 percent. This is a 0.07 percent increase over sales of $37.153 million the same period last year.